Related Experiment Video
Updated: Aug 15, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 19, 2013
Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer
T C Thompson1, S H Park, T L Timme
1Department of Urology, Baylor College of Medicine, Houston, Texas.
Abstract:
To study the interactions between dominantly acting oncogenes and tumor suppressor genes we used p53 'knockout' mouse urogenital sinus tissue for retroviral transduction of ras and myc in the mouse prostate reconstitution (MPR) model system. Epithelial hyperplasia was observed in all wild-type p53 MPRs with one small focal cancer and no evidence of metastasis. Prostatic cancer was found in 100% of the heterozygous and homozygous p53 mutant MPRs with metastatic deposits in 95% of the mice. The pattern of metastasis was remarkably similar to that in human prostate cancer with gross metastatic deposits in the lung, lymph nodes, bone and liver of many animals. Progression of carcinomas in the ras+myc-initiated heterozygous p53 mutant MPRs was invariably associated with either complete loss, partial deletion or loss of expression of the wild-type p53 allele. Southern blotting analysis of proviral-cellular DNA junction fragments in primary carcinomas and cell lines derived from metastatic deposits revealed that metastases do not necessarily seed out from the most abundant clone in the primary carcinoma.
Insights
Loss of p53 tumor suppressor gene function accelerates prostate cancer development and metastasis in mice. This study highlights p53
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Tumor suppressor genes, like p53, are critical in preventing cancer.
- Oncogenes (e.g., ras, myc) drive cell growth and can initiate cancer.
- Understanding their interactions is key to cancer research.
Purpose of the Study:
- To investigate how p53 gene status affects cancer progression when oncogenes are activated.
- To model prostate cancer development and metastasis using the mouse prostate reconstitution (MPR) system.
Main Methods:
- Utilized p53 'knockout' mouse urogenital sinus tissue.
- Employed retroviral transduction of ras and myc oncogenes within the MPR model.
- Analyzed tumor formation, metastasis, and p53 allele status.
Main Results:
- Wild-type p53 mice showed hyperplasia but limited cancer.
- p53 mutant mice (heterozygous and homozygous) developed prostate cancer in 100% of cases.
- Metastasis to lung, lymph nodes, bone, and liver occurred in 95% of p53 mutant mice.
- Cancer progression correlated with loss or deletion of the wild-type p53 allele.
- Metastases did not always originate from the dominant clone in primary tumors.
Conclusions:
- p53 loss significantly promotes prostate cancer initiation, progression, and metastasis.
- The loss of wild-type p53 function is a critical event in advanced prostate cancer.
- Metastatic seeding may involve minor clones within the primary tumor.
Related Concept Videos
Abnormal Proliferation
The Ras Gene
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

